Your browser doesn't support javascript.
loading
Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients.
Tjon-Kon-Fat, Lee-Ann; Lundholm, Marie; Schröder, Mona; Wurdinger, Thomas; Thellenberg-Karlsson, Camilla; Widmark, Anders; Wikström, Pernilla; Nilsson, Rolf Jonas Andreas.
Afiliação
  • Tjon-Kon-Fat LA; Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden.
  • Lundholm M; Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden.
  • Schröder M; Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden.
  • Wurdinger T; Department of Neurosurgery, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Thellenberg-Karlsson C; Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden.
  • Widmark A; Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden.
  • Wikström P; Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden.
  • Nilsson RJA; Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden.
Prostate ; 78(1): 48-53, 2018 Jan.
Article em En | MEDLINE | ID: mdl-29094381
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plaquetas / Neoplasias de Próstata Resistentes à Castração / Androstenos / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plaquetas / Neoplasias de Próstata Resistentes à Castração / Androstenos / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article